BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 4, 2015, Pages 1615-1619

  Balasubramanian, Anandh ^a   Subramaniam, Ramkumar ^a   Narayanan, Vivek ^b   Annamalai, Thangavelu ^c   Ramanathan, Arvind ^d  

^a SRI RAMACHANDRA UNIVERSITY   (India)

^b Kattankulathur   (India)

^c ANNAMALAI UNIVERSITY   (India)

^d Enable Biolabs Madurai Meenakshipuram Extension   (India)

Author keywords

BRD7 expression; Differentiation marker; Hypermethylation; Oral carcinoma

Indexed keywords

BRD7 PROTEIN, HUMAN; DNA; NONHISTONE PROTEIN;

CANCER STAGING; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOLECULAR GENETICS; MOUTH TUMOR; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; SQUAMOUS CELL CARCINOMA;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC;

EID: 84926189784     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.4.1615     Document Type: Article

References (23)

1. Asokan GS, Jeelani S, Gnanasundaram N (2014). Promoter hypermethylation profile of tumour suppressor genes in oral leukoplakia and oral squamous cell carcinoma. J Clin Diagn Res, 8, 9-12.
2. Bakhtiar SM, Ali A, Barh D (2015). Epigenetics in head and neck cancer. Methods Mol Biol, 1238, 751-69.
3. Bhatia V, Goel MM, Makker A, et al (2014). Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma. Biomed Res Int, 2014, 248419.
4. Drost J, Mantovani F, Tocco F, et al (2010) BRD7 is a candidate tumour suppressor gene required for p53 function. Nat Cell Biol, 12, 380-9.
5. Ehrlich M (2009). DNA hypomethylation in cancer cells. Epigenomics, 1, 239-59.
6. Gunn P, Walsh S, Roux C (2014). The nucleic acid revolution continues-will forensic biology become forensic molecular biology? Front Genet, 5, 44.
7. Goldberg AD, Allis CD, Bernstein E (2007). Epigenetics: a landscape takes shape. Cell, 128, 635-8.
8. Hagemann S, Heil O, Lyko F, Brueckner B (2011). Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines. PLoS ONE, 6, 17388.
9. Jiang N, Wang L, Chen J, et al (2014). Conserved and divergent patterns of DNA methylation in higher vertebrates. Genome Biol Evol, 6, 2998-3014.
10. Kanherkar RR, Bhatia-Dey N, Csoka AB (2014). Epigenetics across the human lifespan. Front Cell Dev Biol, 2, 49.
11. Li LL, Shu XS, Wang ZH, Cao Y, Tao Q (2011). Epigenetic disruption of cell signaling in nasopharyngeal carcinoma. Chin J Cancer, 30, 231-9.
12. Mantovani F, Drost J, Voorhoeve PM, Del Sal G, Agami R (2010). Gene regulation and tumor suppression by the bromodomain-containing protein BRD7. Cell Cycle, 9, 2777-81.
13. Martin LJ, Wong M (2013). Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms. Neurotherapeutics, 10, 722-33.
14. Mehta DT, Annamalai T, Ramanathan A (2014). Lack of mutations in protein tyrosine kinase domain coding exons 19 and 21 of the EGFR gene in oral squamous cell carcinomas. Asian Pac J Cancer Prev, 15, 4623-7.
15. Miao Y, Wang L, Zhang X, et al (2014). Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis. PLoS One, 9, 112258.
16. Mishra A, Meherotra R (2014). Head and neck cancer: global burden and regional trends in India. Asian Pac J Cancer Prev, 15, 537-50.
17. Park YJ, Claus R, Weichenhan D, Plass C (2011). Genome-wide epigenetic modifications in cancer. Prog Drug Res, 67, 25-49.
18. Sen N, Satija YK, Das S (2012). p53 and metabolism: old player in a new game. Transcription, 3, 119-23.
19. Sharan RN, Mehrotra R, Choudhury Y, Asotra K (2012). Association of betel nut with carcinogenesis: revisit with a clinical perspective. PLoS One, 7, 42759.
20. Sharma S, Sambyal V, Guleria K, et al (2014). TP53 polymorphisms in sporadic North Indian breast cancer patients. Asian Pac J Cancer Prev, 15, 6871-9.
21. Tushar MD, Ramanathan A (2013). Tyrosine 1045 codon mutations in exon 27 of EGFR are infrequent in oral squamous cell carcinomas. Asian Pac J Cancer Prev, 14, 4279-82.
22. van Vlodrop IJ, Niessen HE, Derks S, et al (2011) Analysis of promoter CpG island hypermethylation in cancer: location, location, location! Clin Cancer Res, 17, 4225-31.
23. Zhou Z, Guo Y, Liu Y, et al (2014). Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis. Exp Cell Res, 14-4827. [Epub ahead of print].